Oligonucleotides labeled with stable isotopes and a method for detecting the same
OwnerGota Kawai, Akira Wada +1inventors
InventorsGota Kawai, Akira Wada, Hiroshi Tahau
Life of this patent
Estimating the term…
Loading patent…
OwnerGota Kawai, Akira Wada +1inventors
InventorsGota Kawai, Akira Wada, Hiroshi Tahau
Estimating the term…
Antisense oligonucleotide sequences which enable the measurement of the distribution and structure of antisense oligonucleotide drugs in the body, with lapse of time, and a method of detecting these sequences are provided. The antisense chains have a natural or non-natural nucleotide or peptide nucleic acid as a structure unit in which carbon atoms and nitrogen atoms are substituted by 13C and 15N, respectively, and the antisense chains can be detected by nuclear magnet resonance spectrometry (NMR) such as 15N—1H or 13C—1H heteronuclide multiple quantum coherence spectrometry.
An antisense oligonucleotide sequence or antisense peptide nucleic acid sequence comprising a single strand RNA or single strand or double strand DNA containing at least one nucleotide or peptide nucleic acid as a structural unit, in which at least one structural C atom is substituted by 13C, and at least one structural N atom is substituted by 15N, having 10 to 100 bases complementary to the desired target sequence to be hybridized,
Dependencies are inferred from the claim text.